Allegiant Travel ALGT Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Healthcare Services GroupHCSG

-$387K-177%

TFS FinancialTFSL

-$1.91M-136%

GeneDx HoldingsWGS

-$253K-437%

EVERTECEVTC

-$4K-150%

First BanCorpFBP

-$6.17M-107%

BioCryst PharmaceuticalsBCRX

-$344K-122%

Other financials

Income statement

See full

Revenue$732.4M+4.8%

Operating income$81.1M+24.8%

Net income$42.5M+32.3%

EPS (diluted)$2.30+32.9%

Balance sheet

See full

Cash & equivalents$304.6M+0.6%

Total debt$595.0M-23.8%

Total equity$1.1B-1.5%

Total assets$4.4B-2.0%

Cash flow

See full

Operating cash flow$268.1M+40.0%

CapEx$45.4M-39.0%

Free cash flow$222.6M+90.4%

Valuation

See full

Market cap$2.88B+57.8%

Profitability

See full

Operating margin2%+1.1pp

Net margin-11.4%-12.5pp

FCF margin-5%+3.3pp

Returns & leverage

See full

Return on equity-25.3%-27.4pp

Debt / equity0.5×-0.2×

Current ratio0.9×0.0×

Where this comes from

Reported directly by Allegiant Travel in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Allegiant Travel’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allegiant Travel's unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Allegiant Travel's unrealized gains (losses) on available-for-sale securities?: Allegiant Travel (ALGT) reported unrealized gains (losses) on available-for-sale securities of -$1.24M in Q1 2026.
How has Allegiant Travel's unrealized gains (losses) on available-for-sale securities changed year-over-year?: Allegiant Travel's unrealized gains (losses) on available-for-sale securities decreased by 53.2% year-over-year, from -$810K to -$1.24M.